National Law Journal Names Weitz and Luxenberg to ‘Elite Trial Lawyers’ List, Reveals 2 Keys to Firm’s $9-Billion Actos Verdict

NEW YORK, N.Y., Oct. 1, 2014 (SEND2PRESS NEWSWIRE) — Two keys that earlier this year led to a $9-billion courtroom victory by Weitz and Luxenberg, P.C., against the maker of the diabetes drug Actos, were revealed Monday when National Law Journal named the New York City-based personal injury firm to its debut list of ‘America’s Elite Trial Lawyers.’